Clinical Trial Update: Effect of Evolocumab in Patients With Critical Limb Ischemia (Evol-CLI) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating evolocumab in patients with critical limb ischemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Critical Limb Ischemia

Drugs mentioned

• Evolocumab (evolocumab)

Snippet

Sponsor: Leonardo Clavijo | Conditions: Critical Limb Ischemia | Phase 4 | Status: UNKNOWN